Market Outlook : Colorectal Cancer Therapeutics Market in APAC Grow at a CAGR of 6.32% by 2019

ResearchMoz presents professional and in-depth study of “Colorectal Cancer Therapeutics Market in APAC 2015-2019”.

Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain. Colorectal cancer can be classified into four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies.

Technavio’s analysts forecast the colorectal cancer therapeutics market in APAC to grow at a CAGR of 6.32% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the colorectal cancer therapeutics market in APAC for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various drugs used in the treatment of colorectal cancer. The colorectal cancer therapeutics market in APAC is segmented based on lines of chemotherapy: first-line chemotherapy and second-line chemotherapy.

Technavio’s report, Colorectal Cancer Therapeutics Market in APAC 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC; it also covers the landscape of the colorectal cancer therapeutics market in APAC and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=494361

Key regions
APAC
China
Japan

Key vendors
Amgen
Bayer
Bristol-Myers Squibb
Chugai Pharmaceuticals
Merck
Sanofi

Other prominent vendors
Accord Healthcare
Advenchen Laboratories
Aeterna Zentaris
AstraZeneca
AVEO Oncology
Bavarian Nordic
Biothera
Boehringer Ingelheim
Boston Biomedical
Cancer Prevention Pharmaceuticals
Celator Pharmaceuticals
Daiichi Sankyo
Debiopharm
Eisai
Eli Lilly
EpicentRx
GlaxoSmithKline
Hutchison Medipharma
Immodulon Therapeutics
Immunomedics
MacroGenics
Merrimack Pharmaceuticals
MolMed
Mologen
Morphotek
Mylan
Nektar Therapeutics
Oncothyreon
Otsuka Pharmaceutical
PledPharma
Precision Biologics
PsiOxus Therapeutics
Sun Pharmaceutical
Symphogen
Taiho
Takeda
Teva Pharmaceuticals
ThromboGenics
Xbiotech
Yakult Honsha

Key market driver
Increase in aging population
For a full, detailed list, view our report

Key market challenge
Unknown disease etiology
For a full, detailed list, view our report

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=494361

Key market trend
Rise in public awareness
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States – 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/

%d bloggers like this: